Sommer, R; Augustin, M; Reguiai, Z; Gerdes, S; Dauden, E; Weger, W; Maul, JT; Laws, P; Naldi, L; Ghislain, PD; Jong, ED; Mburu, S; Koscielny, V; Massana, E; Kasujee, I; Mrowietz, U.
PATIENT-REPORTED WELL-BEING USING TILDRAKIZUMAB IN A REAL-WORLD SETTING: 52WEEK INTERIM DATA OF THE PHASE IV POSITIVE STUDY
ACTA DERM-VENEREOL. 2024; 104: -7th IFPA Conference; JUN 27-29, 2024; Stockholm, SWEDEN.
[Oral Communication]
Web of Science